Zhao Jiandong, Yuan Yongyi, Huang Shasha, Huang Bangqing, Cheng Jing, Kang Dongyang, Wang Guojian, Han Dongyi, Dai Pu
Department of Otolaryngology, PLA General Hospital, Beijing, People's Republic of China.
Department of Otolaryngology, PLA General Hospital, Beijing, People's Republic of China; Department of Otolaryngology, Hainan Branch of PLA General Hospital, Sanya, People's Republic of China.
PLoS One. 2014 Nov 5;9(11):e108134. doi: 10.1371/journal.pone.0108134. eCollection 2014.
Nonsyndromic enlargement of vestibular aqueduct (NSEVA) is an autosomal recessive hearing loss disorder that is associated with mutations in SLC26A4. However, not all patients with NSEVA carry biallelic mutations in SLC26A4. A recent study proposed that single mutations in both SLC26A4 and KCNJ10 lead to digenic NSEVA. We examined whether KCNJ10 excert a role in the pathogenesis of NSEVA in Chinese patients.
SLC26A4 was sequenced in 1056 Chinese patients with NSEVA. KCNJ10 was screened in 131 patients who lacked mutations in either one or both alleles of SLC26A4. Additionally, KCNJ10 was screened in 840 controls, including 563 patients diagnosed with NSEVA who carried biallelic SLC26A4 mutations, 48 patients with nonsyndromic hearing loss due to inner ear malformations that did not involve enlargement of the vestibular aqueduct (EVA), 96 patients with conductive hearing loss due to various causes, and 133 normal-hearing individuals with no family history of hereditary hearing loss.
925 NSEVA patients were found carrying two-allele pathogenic SLC26A4 mutations. The most frequently detected KCNJ10 mutation was c.812G>A (p.R271H). Compared with the normal-hearing control subjects, the occurrence rate of c.812G>A in NSEVA patients with lacking mutations in one or both alleles of SLC26A4 had no significant difference(1.53% vs. 5.30%, χ(2) = 2.798, p = 0.172), which suggested that it is probably a nonpathogenic benign variant. KCNJ10 c.1042C>T (p.R348C), the reported EVA-related mutation, was not found in patients with NSEVA who lacked mutations in either one or both alleles of SLC26A4. Furthermore, the normal-hearing parents of patients with NSEVA having two SLC26A4 mutations carried the KCNJ10 c.1042C>T or c.812G>A mutation and a SLC26A4 pathogenic mutation.
SLC26A4 is the major genetic cause in Chinese NSEVA patients, accounting for 87.59%. KCNJ10 may not be a contributor to NSEVA in Chinese population. Other genetic or environmental factors are possibly play a role in the etiology of Chinese EVA patients with zero or monoallelic SLC26A4 mutation.
非综合征性前庭导水管扩大(NSEVA)是一种常染色体隐性遗传性听力损失疾病,与SLC26A4基因突变相关。然而,并非所有NSEVA患者都携带SLC26A4双等位基因突变。最近一项研究提出,SLC26A4和KCNJ10的单基因突变会导致双基因NSEVA。我们研究了KCNJ10在中国NSEVA患者发病机制中是否发挥作用。
对1056例中国NSEVA患者进行SLC26A4基因测序。对131例SLC26A4一个或两个等位基因均无突变的患者进行KCNJ10基因筛查。此外,对840名对照者进行KCNJ10基因筛查,其中包括563例携带SLC26A4双等位基因突变的NSEVA患者、48例因内耳畸形而非前庭导水管扩大(EVA)导致的非综合征性听力损失患者、96例因各种原因导致的传导性听力损失患者以及133名无遗传性听力损失家族史的听力正常个体。
发现925例NSEVA患者携带双等位基因致病性SLC26A4突变。最常检测到的KCNJ10突变是c.812G>A(p.R271H)。与听力正常的对照者相比,SLC26A4一个或两个等位基因均无突变的NSEVA患者中c.812G>A的发生率无显著差异(1.53%对5.30%,χ(2)=2.798,p=0.172),这表明它可能是一种非致病性良性变异。在SLC26A4一个或两个等位基因均无突变的NSEVA患者中未发现已报道的与EVA相关的KCNJ10 c.1042C>T(p.R348C)突变。此外,具有两个SLC26A4突变的NSEVA患者的听力正常父母携带KCNJ10 c.1042C>T或c.812G>A突变以及一个SLC26A4致病性突变。
SLC26A4是中国NSEVA患者的主要遗传病因,占87.59%。KCNJ10可能不是中国人群中NSEVA的致病因素。其他遗传或环境因素可能在SLC26A4突变零个或单等位基因的中国EVA患者病因中起作用。